5 May 2023
Pharmaceuticals | Top 5 Selected Papers in 2021–2022 in the Section “Medicinal Chemistry”
You are accessing a machine-readable page. In order to be human-readable, please install an RSS reader.
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Feature papers represent the most advanced research with significant potential for high impact in the field. A Feature Paper should be a substantial original Article that involves several techniques or approaches, provides an outlook for future research directions and describes possible research applications.
Feature papers are submitted upon individual invitation or recommendation by the scientific editors and must receive positive feedback from the reviewers.
Editor’s Choice articles are based on recommendations by the scientific editors of MDPI journals from around the world. Editors select a small number of articles recently published in the journal that they believe will be particularly interesting to readers, or important in the respective research area. The aim is to provide a snapshot of some of the most exciting work published in the various research areas of the journal.
Original Submission Date Received: .
1. “1,2,4-Triazoles as Important Antibacterial Agents”
by Małgorzata Strzelecka and Piotr Świątek
Pharmaceuticals 2021, 14(3), 224; https://doi.org/10.3390/ph14030224
Available online: https://www.mdpi.com/1424-8247/14/3/224
2. “Pharmaceutical Drugs and Natural Therapeutic Products for the Treatment of Type 2 Diabetes Mellitus”
by Jana Blahova, Monika Martiniakova, Martina Babikova, Veronika Kovacova, Vladimira Mondockova and Radoslav Omelka
Pharmaceuticals 2021, 14(8), 806; https://doi.org/10.3390/ph14080806
Available online: https://www.mdpi.com/1424-8247/14/8/806
3. “Synthesis and Anticancer Evaluation of New 1,3,4-Oxadiazole Derivatives”
by Camelia Elena Stecoza, George Mihai Nitulescu, Constantin Draghici, Miron Teodor Caproiu, Octavian Tudorel Olaru, Marinela Bostan and Mirela Mihaila
Pharmaceuticals 2021, 14(5), 438; https://doi.org/10.3390/ph14050438
Available online: https://www.mdpi.com/1424-8247/14/5/438
4. “Chiral Switch: Between Therapeutical Benefit and Marketing Strategy”
by Gabriel Hancu and Adriana Modroiu
Pharmaceuticals 2022, 15(2), 240; https://doi.org/10.3390/ph15020240
Available online: https://www.mdpi.com/1424-8247/15/2/240
5. “Unveiling the Multitarget Anti-Alzheimer Drug Discovery Landscape: A Bibliometric Analysis”
by Anna Sampietro, F. Javier Pérez-Areales, Paula Martínez, Elsa M. Arce, Carles Galdeano and Diego Muñoz-Torrero
Pharmaceuticals 2022, 15(5), 545; https://doi.org/10.3390/ph15050545
Available online: https://www.mdpi.com/1424-8247/15/5/545